dabigatran etexilate

The drug is used for the primary prevention of venous thromboembolic complications in adult patients who have undergone major orthopedic surgery for knee or hip replacement.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Oman Pharmaceutical Products Co. LLC (manufacturing, packaging, quality control of medicinal product batch)

The drug is used to prevent venous thromboembolic complications following hip or knee replacement surgery. It is also prescribed to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment and prevention of recurrences of deep vein thrombosis and pulmonary embolism.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Oman Pharmaceutical Products Co. LLC (manufacturing, packaging, quality control of medicinal product batch)

The drug is used to prevent stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis and pulmonary embolism, as well as for the prevention of their recurrence.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Oman Pharmaceutical Products Co. LLC (manufacturing, packaging, quality control of medicinal product batch)

The drug is prescribed for the primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip or knee replacement surgery.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG

The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis and pulmonary embolism, as well as for the prevention of recurrent cases of these diseases. Additionally, Pradaxa is used for the primary prevention of thrombosis following elective hip or knee replacement surgery.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG

The drug is prescribed for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (in the presence of risk factors such as age 75 or older, diabetes, hypertension, etc.), as well as for the treatment and prevention of recurrence of deep vein thrombosis and pulmonary embolism.

Form: capsules, hard

ATC: B01AE07

Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG